Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases (Q39012302)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 April 2015

Language	Label	Description	Also known as
English	Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases	scientific article published on 30 April 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

inflammatory bowel diseases

0 references

Jakub Piotr Fichna

4

object named as

J Fichna

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

A Jarmuż

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

M Zielińska

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

M Storr

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

30 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1057-1068

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Epidemiology of constipation in North America: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Guanylate cyclase-C receptor activation: unexpected biology

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Transmembrane guanylate cyclase in intestinal pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

The relevance of N-linked glycosylation to the binding of a ligand to guanylate cyclase C.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Uroguanylin regulates net fluid secretion via the NHE2 isoform of the Na/H+ exchanger in an intestinal cellular model.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Chloride secretion in response to guanylin in colonic epithelial from normal and transgenic cystic fibrosis mice

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl- channel activation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Current understanding of guanylin peptides actions.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Analysis of the human guanylin gene and the processing and cellular localization of the peptide

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Precursor structure, expression, and tissue distribution of human guanylin

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Human guanylin: cDNA isolation, structure, and activity

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Uroguanylin gene expression in the alimentary tract and extra-gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

The guanylin peptide family and the proposed gastrointestinal-renal natriuretic signaling axis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Uroguanylin and guanylin: distinct but overlapping patterns of messenger RNA expression in mouse intestine

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Enterochromaffin cells of the digestive system: cellular source of guanylin, a guanylate cyclase-activating peptide

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Low salt intake down-regulates the guanylin signaling pathway in rat distal colon

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Intestinal goblet cells and mucins in health and disease: recent insights and progress

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

News from the End of the Gut-How the Highly Segmental Pattern of Colonic HCO3- Transport Relates to Absorptive Function and Mucosal Integrity

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Peripheral mechanisms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Neuroendocrine and neuroimmune markers in IBS: pathophysiological role or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Irritable bowel syndrome: the role of gut neuroendocrine peptides

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

New treatment targets for the management of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Serotonergic agents and the irritable bowel syndrome: what goes wrong?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Brain-Gut Interactions in IBS

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

What is chronic constipation? Definition and diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Two randomized trials of linaclotide for chronic constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Non-IBD colitides (eosinophilic, microscopic).

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

The epidemiology of inflammatory bowel disease in Canada: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Review: Current trends in inflammatory bowel disease: the natural history

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Epithelial barrier biology: good fences make good neighbours

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

NF-κB and the link between inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12574

21 January 2018

Identifiers

10.1111/NMO.12574

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39012302&oldid=1802364418"